Increased arterial inflammation in individuals with stage 3 chronic kidney disease

Richard A P Takx1,2, Megan H MacNabb1, Hamed Emami1

  • 1Cardiac MR PET CT Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Insights

Patients with chronic kidney disease (CKD) exhibit increased arterial inflammation, even in mild stages. This inflammation is linked to reduced kidney function and occurs independently of atherosclerosis, suggesting current risk assessments may be insufficient.

Area of Science:

  • Cardiovascular Imaging
  • Nephrology
  • Radiology

Background:

  • Chronic kidney disease (CKD) is a known risk factor for atherosclerosis.
  • The relationship between mild CKD and arterial inflammation remains unclear.
  • 18F-FDG PET/CT is a valuable tool for assessing arterial inflammation.

Purpose of the Study:

  • To compare arterial inflammation in patients with mild CKD versus matched controls.
  • To investigate the association between arterial inflammation and estimated glomerular filtration rate (eGFR).
  • To determine if arterial inflammation in CKD is independent of coronary artery calcification (CAC).

Main Methods:

  • A retrospective study of 128 patients (64 with stage 3 CKD, 64 controls) undergoing 18F-FDG PET/CT.
  • Arterial inflammation measured by 18F-FDG uptake in the ascending aorta.
  • Coronary artery calcification (CAC) assessed via CT imaging.
  • Analysis adjusted for background uptake and clinical risk factors.

Main Results:

  • Arterial inflammation was significantly higher in CKD patients compared to controls (SUV: 2.41 ± 0.49 vs. 2.16 ± 0.43, p=0.002).
  • Arterial inflammation correlated inversely with eGFR (r=-0.299, p=0.001).
  • Increased arterial inflammation in CKD was independent of CAC and clinical risk factors.

Conclusions:

  • Moderate CKD is associated with elevated arterial inflammation.
  • This inflammation is independent of subclinical atherosclerosis (CAC).
  • Current cardiovascular risk stratification may underestimate atherosclerosis risk in CKD patients.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
957
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
625
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.2K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
490
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.4K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.9K